» » New fusion protein, useful for selective treatment of T cell tumors, comprises T cell ligand linked to cytostatic or immunostimulating component
Информация к новости
  • Просмотров: 2812
  • Автор: admin
  • Дата: 20-01-2014, 21:30
20-01-2014, 21:30

New fusion protein, useful for selective treatment of T cell tumors, comprises T cell ligand linked to cytostatic or immunostimulating component

Category: Patents

DE10161738 (A1)
New fusion protein, useful for selective treatment of T cell tumors, comprises T cell ligand linked to cytostatic or immunostimulating component

DE10161738 (A1)
Back Комментариев: 0

Our Webseite Recommends:

Распечатать